Sign Up to like & get
recommendations!
2
Published in 2022 at "Scientific Reports"
DOI: 10.1038/s41598-022-05788-6
Abstract: As the first dose of Gam-COVID-Vac, is currently used as a single dose vaccine in some countries, we investigated the immunogenicity of this at 4 weeks (327 naïve individuals). 88.7% seroconverted, with significantly lower seroconversion…
read more here.
Keywords:
first dose;
gam covid;
covid vac;
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.894277
Abstract: Background Scarce information exists in relation to the comparison of seroconversion and adverse events following immunization (AEFI) with different SARS-CoV-2 vaccines. Our aim was to correlate the magnitude of the antibody response to vaccination with…
read more here.
Keywords:
immunization;
sars cov;
covid vac;
adverse events ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Vaccines"
DOI: 10.3390/vaccines10030370
Abstract: The Republic of San Marino COVID-19 vaccination campaign used Gam-COVID-Vac and Pfizer-BioNTech vaccines. To assess adverse events following immunization (AEFIs), approximately 6000 vaccine recipients were monitored by the ROCCA study, including subgroups with Parkinson’s Disease…
read more here.
Keywords:
biontech vaccines;
group;
covid vac;
study ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Clinical and Experimental Vaccine Research"
DOI: 10.7774/cevr.2022.11.2.230
Abstract: International travel is rebounding as coronavirus disease 2019 (COVID-19) vaccinations continue and more countries are opting for ‘living with COVID’ in the hopes of moving from a pandemic footing toward an endemic one. Such travel…
read more here.
Keywords:
travel;
covid;
international travel;
covid vac ... See more keywords